🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Relmada Therapeutics, Inc.
Market Cap: Low
Employees: Lowest
Esmethadone (d-methadone, dextromethadone, REL-1017)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing products for central nervous system (CNS) diseases. Their lead product, Esmethadone, is in Phase 3 clinical trials for treating major depressive disorder.
Symbol: RLMD
Recent Price: $0.46
Industry: Biotechnology
CEO: Dr. Sergio Traversa M.B.A., Pharm.D.
Sector: Healthcare
Employees: 20
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL 33134
Phone: 786 629 1376
Last updated: 2024-12-31